Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Ageusia, Diarrhoea, Epistaxis, Fatigue
Clinical narrative: The pain was so severe in her throat and mouth; The pain was so severe in her throat and mouth; allergic reaction; Oesophageal pain; her fatigue has gone; felt like her throat was closing in on her; Swollen lymph nodes; oral thrush, a fungal infection; covid-like symptoms; This is a spontaneous report from a contactable consumer( the Patient, reported for self)  A 45-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL9262, Expiry date: May2021), via an Intra-muscular route of administration, administered in left arm on 23Jan2021 at 15:45 as a single dose for COVID-19 immunization (preventative) at hospital.   Medical history included ongoing anxiety (Additional Information for Other Conditions: diagnosed years ago). Other Relevant Med History was none. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available or prior vaccinations were none. Additional Vaccines Administered on Same Date of the Pfizer Suspect were none. Prior Vaccinations (within 4 weeks) includes: flu shot but she is not sure when. Concomitant medications included buspirone (15mg tablet once a day by mouth) taken for anxiety from an unspecified start date and ongoing.   On 30Jan2021, patient experienced COVID- like symptoms. On 31Jan2021, patient experienced Oral thrush. On 01Feb2021, patient experienced Swollen lymph nodes. Reporter stated that She was calling to report an allergic reaction to the first dose of the Pfizer COVID vaccine. Patient was having oral thrush, a fungal infection. In doing her research she has found that multiple people are coming back with the same reaction and it is connected to polyglycerol. Patient heard there was a patch out to see if someone is allergic to polyglycerol. She has been in contact with VAERS, the health department and CDC.   Patient stated that she started with COVID-like symptoms on 30Jan2021. Then she had pain from the oral thrush in the bottom of her lower esophagus which then went up to her mid esophagus. Patient was treating with salt water on Monday. She had swollen lymph nodes on Monday. She went to her primary care doctor on 02Feb2021 and she was given a suspension. The pain was so severe in her throat and mouth, she felt like her throat was closing in on her and she was referred to the Emergency Room (ER). Patient went to ER on 03Feb2021. She confirms she was not admitted to the hospital. She called her dentist on 03Feb2021 and they ordered a mouth rinse with lidocaine and the mouth rinse is what started her on the road recovery since it is numbing her throat and mouth.    Patient was a teacher. She is scheduled to receive a second dose on 13Feb2021. She is hearing from the research she is reading that the symptoms experienced with the second dose could be up to 3 times as bad as what one would experience from the first dose. Advised to consult with hcp about receiving the second dose. Her school nurse called to ask if a 300 pound person would receive the same dose as a 115 pound person and she was told the same dose would be received. She is asking where this is coming from. Patient was visited to emergency room and physician office for the events. COVID-like symptoms: Patient stated she was in bed for 5 days, her fatigue has gone away since her mouth and throat have started to heal. States this is her first day back working virtually.  The outcome of the events was reported as recovering for oral thrush, a fungal infection; Swollen lymph nodes (they were tender not as swollen); Outcome for event fatigue reported as recovered; and unknown for other events.    Follow-up (27May2021): Follow-up attempts completed. No further information expected.